Compagnie Lombard Odier SCmA’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,000
| Closed | -$18.5K | – | 648 |
|
|
2023
Q3 | $18.5K | Hold |
1,000
| – | – | ﹤0.01% | 491 |
|
|
2023
Q2 | $11.1K | Hold |
1,000
| – | – | ﹤0.01% | 498 |
|
|
2023
Q1 | $13.4K | Hold |
1,000
| – | – | ﹤0.01% | 540 |
|
|
2022
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 594 |
|
|
2022
Q3 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 556 |
|
|
2022
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 533 |
|
|
2022
Q1 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 534 |
|
|
2021
Q4 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 603 |
|
|
2021
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 582 |
|
|
2021
Q2 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 556 |
|
|
2021
Q1 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 566 |
|
|
2020
Q4 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 491 |
|
|
2020
Q3 | $41K | Hold |
1,000
| – | – | ﹤0.01% | 402 |
|
|
2020
Q2 | $48K | Hold |
1,000
| – | – | ﹤0.01% | 378 |
|
|
2020
Q1 | $63K | Hold |
1,000
| – | – | ﹤0.01% | 339 |
|
|
2019
Q4 | $124K | Hold |
1,000
| – | – | ﹤0.01% | 293 |
|
|
2019
Q3 | $66K | Hold |
1,000
| – | – | ﹤0.01% | 343 |
|
|
2019
Q2 | $80K | Buy |
+1,000
| New | +$89.5K | ﹤0.01% | 330 |
|
|
2017
Q4 | – | Sell |
-1,549
| Closed | -$90K | – | 730 |
|
|
2017
Q3 | $90K | Buy |
+1,549
| New | +$167K | ﹤0.01% | 452 |
|
|
2017
Q2 | – | Sell |
-1,759
| Closed | -$199K | – | 770 |
|
|
2017
Q1 | $199K | Buy |
+1,759
| New | +$205K | 0.01% | 369 |
|
|
2016
Q3 | – | Sell |
-2,436
| Closed | -$348K | – | 940 |
|
|
2016
Q2 | $348K | Sell |
2,436
-1,151
| -32% | -$168K | 0.01% | 401 |
|
|
2016
Q1 | $461K | Buy |
+3,587
| New | +$424K | 0.01% | 349 |
|
|
2015
Q2 | – | Sell |
-40
| Closed | -$11K | – | 951 |
|
|
2015
Q1 | $11K | Hold |
40
| – | – | ﹤0.01% | 895 |
|
|
2014
Q4 | $6K | Buy |
+40
| New | +$7.39K | ﹤0.01% | 734 |
|
Compagnie Lombard Odier SCmA's ICPT Position: Q4 2023 in Review
Compagnie Lombard Odier SCmA sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,000 shares — an estimated $18.5K sold.
Compagnie Lombard Odier SCmA first reported a position in ICPT in Q4 2014 and held it in 24 quarters. The position peaked at $461K in Q1 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Compagnie Lombard Odier SCmA reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 1,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $18.5K.
- Compagnie Lombard Odier SCmA first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 24 quarters.
- Compagnie Lombard Odier SCmA's Intercept Pharmaceuticals, Inc. position peaked at $461K in Q1 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2023, filed 16 Jan 2024.